| Identification | Back Directory | [Name]
6H-Dibenzo[b,d]pyran-1-ol, 6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, 1-acetate, (6aR,10aR)- | [CAS]
23050-54-6 | [Synonyms]
6H-Dibenzo[b,d]pyran-1-ol, 6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, 1-acetate, (6aR,10aR)- | [Molecular Formula]
C23H32O3 | [MOL File]
23050-54-6.mol | [Molecular Weight]
356.5 |
| Hazard Information | Back Directory | [Description]
Δ8-THC Acetate (CRM) is a certified reference material that is structurally similar to known phytocannabinoids. Δ8-THC is regulated as a Schedule I compound in the United States. Δ8-THC Acetate (CRM) is provided as a DEA exempt preparation. This product is intended for research and forensic applications. | [Uses]
Delta8-THC acetate (Delta8-tetrahydrocannabinol) is a psychoactive phytocannabinoid, that binds to cannabinoid receptor 1 (CB1 receptor), and exhibits anti-nausea, appetite-stimulating, and anti-inflammatory activities. Delta8-THC acetate exhibits probably neuroprotective efficacy and can be used in anti-anxiety and antidepressant research[1]. | [References]
[1] Hayakawa K, et al., Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke. Pharmaceuticals (Basel). 2010 Jul 8;3(7):2197-2212. DOI:10.3390/ph3072197 |
|
| Company Name: |
TargetMol
|
| Tel: |
400-821-0310 15002144251 |
| Website: |
www.targetmol.cn/ |
|